Safety of COVID-19 Vaccines Among the Paediatric Population: Analysis of the European Surveillance Systems and Pivotal Clinical Trials

Autor: Ahmadizar F., Luxi N., Raethke M., Schmikli S., Riefolo F., Saraswati P. W., Bucsa C., Osman A., Liddiard M., Maques F. B., Petrelli G., Sonderlichova S., Thurin N. H., Villalobos F., Trifiro G., Sturkenboom M., Moretti U., Bellitto C., Ciccimarra F., Gonella L. A., Arzenton E., Chiamulera C., Lora R., Bellantuono D., Sabaini A., Firenze A., Zodda D., Guidotti F., Zappone M., Alagna B., Cutroneo P. M., Minore C., Costantino C., Vitale F., D'Alessandro G., Morreale I., Marsala L., Farinella D., Bavetta S., Fantini M. P., Reno C., Raschi E., Poluzzi E., Sapigni E., Potenza A. M., Podetti D., Nikitina V., Ricciardelli R., Mogheiseh N., Croce S., Paltrinieri B., Castellani S., Sangiorgi E., Selleri M., Lucchesi S., Catucci G., Savini D., Sacripanti C., Faccioli M., Romio M. S., Rossi L., Radici S., Negri G., Fares L., Ajolfi C., Fadda A., Chiarello A., Pieraccini F., Gavioli B., Palazzi S., Tuccori M., Vannacci A., Bonaiuti R., Ravaldi C., Lombardi N., Crescioli G., Gori F., Tessari R., Zandona E., Zanoni G., Senna G., Crivellaro M. A., Cancian M., Venturini F., Ferri M., Leonardi L., Orzetti S., Caccin E., Baldo P., Capuano A., Rafaniello C., Ferrajolo C., Pagliaro C., Mercaldo M., di Giorgio A., Tari M., Manna S., Farina G., Di Mauro C., De Carlo I., Senesi I., Pileggi C., Palleria C., Gallelli L., De Sarro G., de Sarro C., Verduci C., Papadopoli R., Trabace L., Morgese M., Schiavone S., Tucci P., Bove M., Lapi F., Cricelli C., Racagni G., Tonolo S., Fava G., Giuffrida S., Amato V., Gambera M., Montresor V., Mastropasqua D.

Background and Objectives: The European Medicine Agency extended the use of Comirnaty, Spikevax, and Nuvaxovid in paediatrics; thus, these vaccines require additional real-world safety evidence. Herein, we aimed to monitor the safety of COVID-19 vacc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______4094::c8916ae0b4845b6e45ea4bd7d0d193b1
https://hdl.handle.net/11585/928075

Depression and cardiovascular risk—association among Beck Depression Inventory, PCSK9 levels and insulin resistance

Autor: Macchi, C, Favero, C, Ceresa, A, Vigna, L, Conti, D M, Pesatori, A C, Racagni, G, Corsini, A, Ferri, N, Sirtori, C R, Buoli, M, Bollati, V, Ruscica, M

Publikováno v: Cardiovascular Diabetology, Vol 19, Iss 1, Pp 1-11 (2020)
Cardiovascular Diabetology

Background Depression and cardiovascular disease (CVD) are among the most common causes of disability in high-income countries, depression being associated with a 30% increased risk of future CV events. Depression is twice as common in people with di

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::5571986a51bda66eee16ccd5b9131eb5
http://link.springer.com/article/10.1186/s12933-020-01158-6

Chronic cocaine administration modulates the expression of transcription factors involved in midbrain dopaminergic neuron function

Autor: Leo, D., di Porzio, U., Racagni, G., Riva, M.A., Fumagalli, F., Perrone-Capano, C.

Publikováno v: In Experimental Neurology 2007 203(2):472-480

Modifications in Brain CaM Kinase II after Long-Term Treatment with Desmethylimipramine

Autor: Consogno, E, Racagni, G, Popoli, M ^*

Publikováno v: In Neuropsychopharmacology January 2001 24(1):21-30

P.1.24 Prenatal stress interferes with glutamatergic response to acute swim stress at adulthood

Autor: Pasini, M., Fumagalli, F., Drago, F., Racagni, G., Riva, M.A.

Publikováno v: In European Neuropsychopharmacology 2009 19 Supplement 1:S21-S22